FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067837009> ?p ?o ?g. }

• W2067837009 endingPage "6089" @default.
• W2067837009 startingPage "6080" @default.
• W2067837009 abstract "Malignant mesotheliomas (MMs) are very aggressive tumors that respond poorly to standard chemotherapeutic approaches. The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in tumor aggressiveness, in part by mediating cell survival and reducing sensitivity to chemotherapy. Using antibodies recognizing the phosphorylated/activated form of AKT kinases, we observed elevated phospho-AKT staining in 17 of 26 (65%) human MM specimens. In addition, AKT phosphorylation was consistently observed in MMs arising in asbestos-treated mice and in MM cell xenografts. Consistent with reports implicating hepatocyte growth factor (HGF)/Met receptor signaling in MM, all 14 human and murine MM cell lines had HGF-inducible AKT activity. One of nine human MM cell lines had elevated AKT activity under serum-starvation conditions, which was associated with a homozygous deletion of PTEN, the first reported in MM. Treatment of this cell line with the mTOR inhibitor rapamycin resulted in growth arrest in G1 phase. Treatment of MM cells with the PI3K inhibitor LY294002 in combination with cisplatin had greater efficacy in inhibiting cell proliferation and inducing apoptosis than either agent alone. Collectively, these data indicate that MMs frequently express elevated AKT activity, which may be targeted pharmacologically to enhance chemotherapeutic efficacy. These findings also suggest that mouse models of MM may be useful for future preclinical studies of pharmaceuticals targeting the PI3K/AKT pathway." @default.
• W2067837009 created "2016-06-24" @default.
• W2067837009 creator A5005979032 @default.
• W2067837009 creator A5012413299 @default.
• W2067837009 creator A5014868247 @default.
• W2067837009 creator A5016679334 @default.
• W2067837009 creator A5022050409 @default.
• W2067837009 creator A5030239715 @default.
• W2067837009 creator A5035099749 @default.
• W2067837009 creator A5040898114 @default.
• W2067837009 creator A5054111631 @default.
• W2067837009 creator A5077367312 @default.
• W2067837009 date "2005-05-16" @default.
• W2067837009 modified "2023-10-18" @default.
• W2067837009 title "Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth" @default.
• W2067837009 cites W1506304328 @default.
• W2067837009 cites W1594020010 @default.
• W2067837009 cites W1964948442 @default.
• W2067837009 cites W1968109047 @default.
• W2067837009 cites W1973577899 @default.
• W2067837009 cites W1973926629 @default.
• W2067837009 cites W1988609792 @default.
• W2067837009 cites W1993903799 @default.
• W2067837009 cites W1999036451 @default.
• W2067837009 cites W2001443196 @default.
• W2067837009 cites W2004228960 @default.
• W2067837009 cites W2006598620 @default.
• W2067837009 cites W2006985176 @default.
• W2067837009 cites W2026664789 @default.
• W2067837009 cites W2032319312 @default.
• W2067837009 cites W2036254130 @default.
• W2067837009 cites W2037532701 @default.
• W2067837009 cites W2045400845 @default.
• W2067837009 cites W2061066931 @default.
• W2067837009 cites W2065825082 @default.
• W2067837009 cites W2065919583 @default.
• W2067837009 cites W2070872482 @default.
• W2067837009 cites W2072780644 @default.
• W2067837009 cites W2073575984 @default.
• W2067837009 cites W2075329156 @default.
• W2067837009 cites W2090551359 @default.
• W2067837009 cites W2090850110 @default.
• W2067837009 cites W2102103107 @default.
• W2067837009 cites W2102627969 @default.
• W2067837009 cites W2102648794 @default.
• W2067837009 cites W2112349032 @default.
• W2067837009 cites W2129172946 @default.
• W2067837009 cites W2139440398 @default.
• W2067837009 cites W2150696343 @default.
• W2067837009 cites W2164895949 @default.
• W2067837009 cites W64510277 @default.
• W2067837009 doi "https://doi.org/10.1038/sj.onc.1208744" @default.
• W2067837009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15897870" @default.
• W2067837009 hasPublicationYear "2005" @default.
• W2067837009 type Work @default.
• W2067837009 sameAs 2067837009 @default.
• W2067837009 citedByCount "145" @default.
• W2067837009 countsByYear W20678370092012 @default.
• W2067837009 countsByYear W20678370092013 @default.
• W2067837009 countsByYear W20678370092014 @default.
• W2067837009 countsByYear W20678370092015 @default.
• W2067837009 countsByYear W20678370092016 @default.
• W2067837009 countsByYear W20678370092017 @default.
• W2067837009 countsByYear W20678370092018 @default.
• W2067837009 countsByYear W20678370092019 @default.
• W2067837009 countsByYear W20678370092020 @default.
• W2067837009 countsByYear W20678370092021 @default.
• W2067837009 countsByYear W20678370092022 @default.
• W2067837009 crossrefType "journal-article" @default.
• W2067837009 hasAuthorship W2067837009A5005979032 @default.
• W2067837009 hasAuthorship W2067837009A5012413299 @default.
• W2067837009 hasAuthorship W2067837009A5014868247 @default.
• W2067837009 hasAuthorship W2067837009A5016679334 @default.
• W2067837009 hasAuthorship W2067837009A5022050409 @default.
• W2067837009 hasAuthorship W2067837009A5030239715 @default.
• W2067837009 hasAuthorship W2067837009A5035099749 @default.
• W2067837009 hasAuthorship W2067837009A5040898114 @default.
• W2067837009 hasAuthorship W2067837009A5054111631 @default.
• W2067837009 hasAuthorship W2067837009A5077367312 @default.
• W2067837009 hasBestOaLocation W20678370091 @default.
• W2067837009 hasConcept C11960822 @default.
• W2067837009 hasConcept C154137905 @default.
• W2067837009 hasConcept C170493617 @default.
• W2067837009 hasConcept C2776912716 @default.
• W2067837009 hasConcept C2776996007 @default.
• W2067837009 hasConcept C2777609662 @default.
• W2067837009 hasConcept C502942594 @default.
• W2067837009 hasConcept C54355233 @default.
• W2067837009 hasConcept C55493867 @default.
• W2067837009 hasConcept C62112901 @default.
• W2067837009 hasConcept C62478195 @default.
• W2067837009 hasConcept C75217442 @default.
• W2067837009 hasConcept C81885089 @default.
• W2067837009 hasConcept C86554907 @default.
• W2067837009 hasConcept C86803240 @default.
• W2067837009 hasConcept C95444343 @default.
• W2067837009 hasConceptScore W2067837009C11960822 @default.
• W2067837009 hasConceptScore W2067837009C154137905 @default.

• next